Quest PharmaTech Inc.
QPTFF · OTC
7/31/2025 | 4/30/2025 | 1/31/2025 | 10/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.05 | -0.01 | -0.00 | -0.24 |
| FCF Yield | 1.10% | -0.00% | -0.00% | -4.31% |
| EV / EBITDA | -62.08 | 4.95 | 3.45 | -16.14 |
| Quality | ||||
| ROIC | -0.50% | -0.51% | -1.24% | -1.02% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | -0.19 | -0.00 | -0.01 | -3.89 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | -100.00% | -100.00% |
| Free Cash Flow Growth | 23,647.59% | -874.20% | 100.01% | 26.81% |
| Safety | ||||
| Net Debt / EBITDA | -10.77 | 1.15 | -0.47 | -3.33 |
| Interest Coverage | -30.64 | -23.07 | -2,289.26 | -23.66 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |